Diabetes

Diabetes Seminar CME / CPD 

Full Course:  20 AMA PRA Category 1 Credits for CME / CEU / CPD

Short Course:  10 AMA PRA Category 1 Credits for CME / CEU / CPD

Course(s) are appropriate for:  Emergency Physicians, Pediatricians, General Practitioners, Nurses, Nurse Practitioners, and Physician Assistants (PA-C's)

Series 16 (DI16) Topics Include:  Glycemic and Adverse Effects, SGLT2 Inhibitors, Heterogeneity of Response to Calorie-Restricted Diets, Nutritional Guidance, Common Barriers to Health Care, and more. 

To view topic outline of the full or short course, select the Course Type (Full or Short) below:

Full Course:
DI16
Full Course Price:
$580
Short Course:
DI16A, DI16B
Short Course Price:
$485
Format:
Available in Audio format.

Course Topics

Diabetes and the Affordable Care Act

Summarize possible scenarios for repealing the ACA; Identify which provisions are most likely to remain in the ACA and which elements are most likely to change; Discuss potential effects of proposed changes to the ACA on patient care and costs, as well as costs for local, state, and federal governments; Propose frameworks to improve delivery of high-value, affordable care.

The Treatment of Obesity in People with Diabetes: Two Perspectives

Discuss the heterogeneity of response to calorie-restricted diets and diabetes medications; Summarize the benefits of bariatric surgery for long-term reduction of body weight and hemoglobin A1c; Review limitations of studies investigating bariatric surgery that arguably contribute to inaccurate assessment of its effectiveness; Develop structured lifestyle interventions to reduce body weight and improve glycemic control in patients with type 2 diabetes.

Medication Adherence/Vitamin and Mineral Supplements in Diabetes

Identify psychosocial barriers to medication adherence; Develop strategies to improve medication adherence in patients with type 2 diabetes; Describe the function, sources, and absorption of chromium, magnesium, vitamins C and E, and vanadium; Discuss the glycemic effects of and adverse events related to supplementation with chromium, magnesium, vitamins C and E, and vanadium in patients with type 2 diabetes or glucose intolerance.

Highlights of the ADA Clinical Conference 2017 Part I

Review the cardiovascular and renal outcomes from recent trials of sodium-glucose cotransporter 2 (SGLT2) inhibitors; Improve medication adherence using community resources, medication reconciliation, and patient education; Discuss the role and benefits of injectable insulin and glucagon-like peptide-1 (GLP-1) receptor agonists; Calculate and titrate the appropriate doses of long-acting insulin or fixed-dose combinations of insulin and GLP-1 receptor agonists.

Diabetes and Diversity

Summarize trends in the incidence of type 1 and type 2 diabetes in pediatric patients; Implement a multidisciplinary approach to reduce risk for diabetes-related complications in pediatric patients; Encourage adherence in Asian-American patients with type 2 diabetes, accounting for common cultural beliefs; Design diabetes education programs targeted toward reducing common barriers to self-management in African-American and Hispanic populations.

Highlights of the ADA Clinical Conference 2017 Part II

Summarize the long-term benefits of structured interventions for prevention of diabetes and related complications; Manage patients with prediabetes using multiple risk factor interventions; Explain how the heterogeneity of diabetes presentations increases the complexity of obtaining a correct diagnosis; Provide nutritional guidance for patients with type 1 or 2 diabetes.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Diabetes Drugs & Cardiovascular Risk / Five-Year Follow-up to the STAMPEDE Trial

Explain why most trials of antidiabetes drugs before 2015 failed to show reduction in cardiovascular disease; Select patients with type 2 diabetes who would be likely to benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitor or glucagon-like peptide drugs; Describe possible mechanisms of action of SGLT2 inhibitors that may contribute to improved cardiovascular outcomes; Compare long-term outcomes of bariatric surgery and intensive medical therapy for treating type 2 diabetes.

Medication Updates from Diabetes Day 2017

Summarize recent guidelines for incorporation of nonstatin therapies for lipid management; Select patients who would benefit from nonstatin therapies; Compare the efficacy and side effects of SGLT2 inhibitors for cardiovascular and renal outcomes; Discuss ongoing questions needed to confirm the efficacy and safety of SGLT2 inhibitors in a broad population of patients with type 2 diabetes.

Lipid Control/The Role of Specialists in Diabetes Care

Select target goals for low-density lipoprotein (LDL) cholesterol to reduce risk for cardiovascular events in patients with type 2 diabetes and multiple morbidities; Prescribe lifestyle and medical management for lowering lipids in patients with type 2 diabetes and multiple morbidities; Optimize the role of specialist care for management of type 2 diabetes; Discuss barriers to implementation of new diabetes therapies in primary care practice.

Culinary Medicine/Diabetes Management for the Culturally Diverse and the Underserved

Propose ways that patients can apply nutritional principles for weight management to food preparation and repurposing; Address common challenges with implementing principles of the Mediterranean-style diet into real-life food preparation; Advise patients on ways to incorporate healthy eating habits into diets from different cultures, when living in a food desert, and while eating in restaurants; Address common barriers to health care for patients from culturally diverse and medically underserved populations.

Diabetes and the Affordable Care Act

Summarize possible scenarios for repealing the ACA; Identify which provisions are most likely to remain in the ACA and which elements are most likely to change; Discuss potential effects of proposed changes to the ACA on patient care and costs, as well as costs for local, state, and federal governments; Propose frameworks to improve delivery of high-value, affordable care.

Medication Adherence/Vitamin and Mineral Supplements in Diabetes

Identify psychosocial barriers to medication adherence; Develop strategies to improve medication adherence in patients with type 2 diabetes; Describe the function, sources, and absorption of chromium, magnesium, vitamins C and E, and vanadium; Discuss the glycemic effects of and adverse events related to supplementation with chromium, magnesium, vitamins C and E, and vanadium in patients with type 2 diabetes or glucose intolerance.

Diabetes and Diversity

Summarize trends in the incidence of type 1 and type 2 diabetes in pediatric patients; Implement a multidisciplinary approach to reduce risk for diabetes-related complications in pediatric patients; Encourage adherence in Asian-American patients with type 2 diabetes, accounting for common cultural beliefs; Design diabetes education programs targeted toward reducing common barriers to self-management in African-American and Hispanic populations.

Diabetes Drugs & Cardiovascular Risk / Five-Year Follow-up to the STAMPEDE Trial

Explain why most trials of antidiabetes drugs before 2015 failed to show reduction in cardiovascular disease; Select patients with type 2 diabetes who would be likely to benefit from sodium-glucose cotransporter-2 (SGLT2) inhibitor or glucagon-like peptide drugs; Describe possible mechanisms of action of SGLT2 inhibitors that may contribute to improved cardiovascular outcomes; Compare long-term outcomes of bariatric surgery and intensive medical therapy for treating type 2 diabetes.

Lipid Control/The Role of Specialists in Diabetes Care

Select target goals for low-density lipoprotein (LDL) cholesterol to reduce risk for cardiovascular events in patients with type 2 diabetes and multiple morbidities; Prescribe lifestyle and medical management for lowering lipids in patients with type 2 diabetes and multiple morbidities; Optimize the role of specialist care for management of type 2 diabetes; Discuss barriers to implementation of new diabetes therapies in primary care practice.

The Treatment of Obesity in People with Diabetes: Two Perspectives

Discuss the heterogeneity of response to calorie-restricted diets and diabetes medications; Summarize the benefits of bariatric surgery for long-term reduction of body weight and hemoglobin A1c; Review limitations of studies investigating bariatric surgery that arguably contribute to inaccurate assessment of its effectiveness; Develop structured lifestyle interventions to reduce body weight and improve glycemic control in patients with type 2 diabetes.

Highlights of the ADA Clinical Conference 2017 Part I

Review the cardiovascular and renal outcomes from recent trials of sodium-glucose cotransporter 2 (SGLT2) inhibitors; Improve medication adherence using community resources, medication reconciliation, and patient education; Discuss the role and benefits of injectable insulin and glucagon-like peptide-1 (GLP-1) receptor agonists; Calculate and titrate the appropriate doses of long-acting insulin or fixed-dose combinations of insulin and GLP-1 receptor agonists.

Highlights of the ADA Clinical Conference 2017 Part II

Summarize the long-term benefits of structured interventions for prevention of diabetes and related complications; Manage patients with prediabetes using multiple risk factor interventions; Explain how the heterogeneity of diabetes presentations increases the complexity of obtaining a correct diagnosis; Provide nutritional guidance for patients with type 1 or 2 diabetes.

QUALIFIES FOR CLINICAL PHARMACOLOGY

Medication Updates from Diabetes Day 2017

Summarize recent guidelines for incorporation of nonstatin therapies for lipid management; Select patients who would benefit from nonstatin therapies; Compare the efficacy and side effects of SGLT2 inhibitors for cardiovascular and renal outcomes; Discuss ongoing questions needed to confirm the efficacy and safety of SGLT2 inhibitors in a broad population of patients with type 2 diabetes.

Culinary Medicine/Diabetes Management for the Culturally Diverse and the Underserved

Propose ways that patients can apply nutritional principles for weight management to food preparation and repurposing; Address common challenges with implementing principles of the Mediterranean-style diet into real-life food preparation; Advise patients on ways to incorporate healthy eating habits into diets from different cultures, when living in a food desert, and while eating in restaurants; Address common barriers to health care for patients from culturally diverse and medically underserved populations.

Additional Information

Additional Continuing Medical Education options available:

Other courses of interest may include: Pediatrics, Family Practice, Internal Medicine, Obesity, and Nutrition 

If you have taken the current Diabetes CME / CPD Review listed above or if you are seeking additional credits, please visit: Medical Courses Coming Soon.  There you will find abbreviated listings of additional courses available related to this specialty and courses that are soon to be released.